Dr Terrol Duane Marshall, DPM - Medicare Podiatrist in Pendleton, OR

Dr Terrol Duane Marshall, DPM is a medicare enrolled "Podiatrist" provider in Pendleton, Oregon. He went to William M. Scholl College Of Podiatric Medicine and graduated in 1999 and has 25 years of diverse experience with area of expertise as Podiatry. He is a member of the group practice Blue Mountain Foot Specialists Inc and his current practice location is 714 Sw Dorion Ave, Pendleton, Oregon. You can reach out to his office (for appointments etc.) via phone at (541) 276-2372.

Dr Terrol Duane Marshall is licensed to practice in Oregon (license number DP00357) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1861442998.

Contact Information

Dr Terrol Duane Marshall, DPM
714 Sw Dorion Ave,
Pendleton, OR 97801-2086
(541) 276-2372
(541) 276-2411



Healthcare Provider's Profile

Full NameDr Terrol Duane Marshall
GenderMale
SpecialityPodiatry
Experience25 Years
Location714 Sw Dorion Ave, Pendleton, Oregon
Accepts Medicare AssignmentsYes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Terrol Duane Marshall attended and graduated from William M. Scholl College Of Podiatric Medicine in 1999
  NPI Data:
  • NPI Number: 1861442998
  • Provider Enumeration Date: 05/11/2006
  • Last Update Date: 03/01/2019
  Medicare PECOS Information:
  • PECOS PAC ID: 4789655648
  • Enrollment ID: I20040824001144

Medical Identifiers

Medical identifiers for Dr Terrol Duane Marshall such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1861442998NPI-NPPES
P00613653OtherORRAILROAD MEDICARE
234444MedicaidOR

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
213ES0103XPodiatrist - Foot & Ankle Surgery DP00357 (Oregon)Secondary
213E00000XPodiatrist DP00357 (Oregon)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
St Anthony HospitalPendleton, ORHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
Blue Mountain Foot Specialists Inc84260236492

News Archive

TAU researcher develops new antibodies to target and destroy cancer cells

Because cancer cells grow very quickly, chemotherapy is designed to target cells whose numbers grow rapidly. But this treatment comes with a heavy price - many healthy cells essential for body functions are also targeted and killed by the toxin. This dangerous side-effect has prompted researchers to seek better and more selective ways to kill cancer cells inside the body.

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

AbbVie announced today that the U.S. Food and Drug Administration has granted HUMIRA orphan drug designation for the treatment of non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis, a group of rare but serious inflammatory diseases of the eye.

FDA's AI/ML-Based Software as a Medical Device Action Plan released

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.

New approach helps Group Health to increase rates of lifesaving screening for colon cancer

Mailing yearly stool kits-an alternative to the often-dreaded colonoscopy-has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from Group Health Research Institute.

Midwest Compassion Center, Dr. Alan Shackelford join forces to treat epilepsy through medical cannabis

Midwest Compassion Center and Dr. Alan Shackelford join forces in the fight to treat epilepsy through the use of medical cannabis at their Will County dispensary. With growing concerns over the potentially negative side effects of pharmaceuticals and their inability to provide adequate symptom control in as many as 30% of patients with seizures, Dr. Shackelford and MCC will collaborate on research with the goal of developing new treatment options for patients dealing with a debilitating illness or condition, including seizures.

Read more Medical News

› Verified 9 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Terrol Duane Marshall allows following entities to bill medicare on his behalf.
Provider NameBlue Mountain Foot Specialists Inc
Provider TypePart B Supplier - Clinic/group Practice
Provider IdentifiersNPI Number: 1922152024
PECOS PAC ID: 8426023649
Enrollment ID: O20040831001333

News Archive

TAU researcher develops new antibodies to target and destroy cancer cells

Because cancer cells grow very quickly, chemotherapy is designed to target cells whose numbers grow rapidly. But this treatment comes with a heavy price - many healthy cells essential for body functions are also targeted and killed by the toxin. This dangerous side-effect has prompted researchers to seek better and more selective ways to kill cancer cells inside the body.

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

AbbVie announced today that the U.S. Food and Drug Administration has granted HUMIRA orphan drug designation for the treatment of non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis, a group of rare but serious inflammatory diseases of the eye.

FDA's AI/ML-Based Software as a Medical Device Action Plan released

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.

New approach helps Group Health to increase rates of lifesaving screening for colon cancer

Mailing yearly stool kits-an alternative to the often-dreaded colonoscopy-has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from Group Health Research Institute.

Midwest Compassion Center, Dr. Alan Shackelford join forces to treat epilepsy through medical cannabis

Midwest Compassion Center and Dr. Alan Shackelford join forces in the fight to treat epilepsy through the use of medical cannabis at their Will County dispensary. With growing concerns over the potentially negative side effects of pharmaceuticals and their inability to provide adequate symptom control in as many as 30% of patients with seizures, Dr. Shackelford and MCC will collaborate on research with the goal of developing new treatment options for patients dealing with a debilitating illness or condition, including seizures.

Read more Medical News

› Verified 9 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Terrol Duane Marshall is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Terrol Duane Marshall, DPM
714 Sw Dorion Ave,
Pendleton, OR 97801-2086

Ph: (541) 276-2372
Dr Terrol Duane Marshall, DPM
714 Sw Dorion Ave,
Pendleton, OR 97801-2086

Ph: (541) 276-2372

News Archive

TAU researcher develops new antibodies to target and destroy cancer cells

Because cancer cells grow very quickly, chemotherapy is designed to target cells whose numbers grow rapidly. But this treatment comes with a heavy price - many healthy cells essential for body functions are also targeted and killed by the toxin. This dangerous side-effect has prompted researchers to seek better and more selective ways to kill cancer cells inside the body.

AbbVie receives HUMIRA orphan drug designation from FDA for treatment of non-infectious uveitis

AbbVie announced today that the U.S. Food and Drug Administration has granted HUMIRA orphan drug designation for the treatment of non-infectious intermediate, posterior, or pan-uveitis, or chronic non-infectious anterior uveitis, a group of rare but serious inflammatory diseases of the eye.

FDA's AI/ML-Based Software as a Medical Device Action Plan released

Today, the U.S. Food and Drug Administration released the agency's first Artificial Intelligence/Machine Learning (AI/ML)-Based Software as a Medical Device (SaMD) Action Plan. This action plan describes a multi-pronged approach to advance the Agency's oversight of AI/ML-based medical software.

New approach helps Group Health to increase rates of lifesaving screening for colon cancer

Mailing yearly stool kits-an alternative to the often-dreaded colonoscopy-has helped Group Health to boost rates of lifesaving screening for colon cancer, according to new research from Group Health Research Institute.

Midwest Compassion Center, Dr. Alan Shackelford join forces to treat epilepsy through medical cannabis

Midwest Compassion Center and Dr. Alan Shackelford join forces in the fight to treat epilepsy through the use of medical cannabis at their Will County dispensary. With growing concerns over the potentially negative side effects of pharmaceuticals and their inability to provide adequate symptom control in as many as 30% of patients with seizures, Dr. Shackelford and MCC will collaborate on research with the goal of developing new treatment options for patients dealing with a debilitating illness or condition, including seizures.

Read more News

› Verified 9 days ago


Podiatrist in Pendleton, OR

Dr. Daniel F Byrd, D.P.M.
Podiatrist
Medicare: Accepting Medicare Assignments
Practice Location: 714 Sw Dorion Ave, Pendleton, OR 97801
Phone: 541-276-2372    Fax: 541-276-2411
Dr. Mark L Yeske, D.P.M.
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 714 Sw Dorion Ave, Pendleton, OR 97801
Phone: 541-276-2372    Fax: 541-276-2411
Blue Mountain Foot Specialists Inc
Podiatrist
Medicare: Medicare Enrolled
Practice Location: 714 Sw Dorion Ave, Pendleton, OR 97801
Phone: 541-276-2372    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.